Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection

H. Nakase, M. Matsuura& T. Chiba, doi:10.1111/j.1365-2036.2010.04552.x

These new data suggest that GMAA might be safe and effective for UC patients positive for CMV because it does not cause MV reactivation. Because CMV reactivation might affect the clinical outcome of patients with refractory UC,5 GMAA could be a promising option for UC patients with CMV infection. A new clinical trial with a larger number of patients is ongoing to evaluate further the effects of GMA on UC patients with CMV infection

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2010.04552.x